The Ozempic manufacturer, represented in both cases by Fenwick & West, filed one complaint on Wednesday in the District of Delaware, then filed a nearly identical one in the Northern District of West Virginia.
Novo Nordisk Seeks Patent Litigation Barrier to Ozempic Generic
Leave a Reply